Annual Next Gen Immuno Oncology Congress (Immuno Oncology 2018)

Meetings Internationalofficially welcomes all the participants from all over the world to attend international conference on “Annual Next Gen Immuno-Oncology Congress” Scheduled in Paris, France during Oct 25-27, 2018.This conference is Mainly accelerating  on “Immuno-Oncology: The Strategic Supernova In Cancer Today ”This conference acquires a global platform for Oncologists, Doctors, Researchers, Surgeons, Physicians, Young Researchers, business Delegates to Exchange Ideas and knowledge.

Meetings International  provides a global platform for Medical, Biotech, Pharmaceutical and Healthcare Professionals to Exchange Ideas, Knowledge and Networking at 100+ International Conferences. It supports broad scope research and peer review at a broad range of specialists around the world. The key strategic objective of Meetings International is to communicate science and medical research between academia and industry.   

Immuno Oncology Conference  gathering incorporates Plenary lectures, keynote lectures by famous personalities from around the world in addition to poster presentation, young researcher sessions, symposiums, workshop and Exhibitions. It focuses on a wide array of topics that include the following:  Immuno-Oncology studies, Cancer Biomarkers, Immune checkpoint inhibitors, Immune checkpoint inhibitors, Cancer ,Novel Approaches in Cancer & Tumor, Stem Cell Therapy, The current drugs available in immunotherapy (and combinations),.Immune Responses Against Tumors and Transplants, Evaluating response in Immunotherapy, Precision Genomics and Precision Medicine for Immuno Oncology, Cancer Immunotherapy, Technological developments of immuno oncology. Adoptive T cell therapy (ACT), Advances in cancer treatment,Tools and trends in Immuno-Oncology.